Research programme: psychotherapeutics - PLIVA d.d.Alternative Names: PLR 21; PLR 21a; PLR 21b
Latest Information Update: 16 Aug 2007
At a glance
- Originator PLIVA d.d.
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Major depressive disorder; Psychotic disorders
Most Recent Events
- 15 Apr 2005 Preclinical trials in Psychotic disorders in Croatia (unspecified route)
- 15 Apr 2005 Preclinical trials in Depression in Croatia (unspecified route)